Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression

• Status: Active, not recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to determine whether marine omega-3 fatty acids and 5-alpha-reductase inhibitor are effective in the progression of prostate cancer for low-risk prostate cancer patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Hospitalier Universitaire de Québec, CHU de Québec; CHU de Quebec-Universite Laval
• Collaborators: Prostate Cancer Canada; Prostate Cancer Canada Network
• Treatments: Dutasteride

Criteria

Inclusion Criteria:

• Low-risk prostatic neoplasms

• Candidate for active surveillance

• Informed consent

Exclusion Criteria:

• Current fish oil supplementation

• Current NSAID use